Characterization of different regimens for initiating anagrelide in patients with essential thrombocythemia who are intolerant or refractory to their current cytoreductive therapy:...

por Rey, Jérôme, Viallard, Jean-François, Keddad, Karim, Smith, Jonathan, Wilde, Paul, Kiladjian, Jean-Jacques
Publicado en Eur J Haematol (2014)

Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases

por Bareau, Benoît, Rey, Jérôme, Hamidou, Mohamed, Donadieu, Jean, Morcet, Jeff, Reman, Oumedaly, Schleinitz, Nicolas, Tournilhac, Olivier, Roussel, Mikael, Fest, Thierry, Lamy, Thierry
Publicado 2010

Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in N...

por Rey, Jérôme, Fauriat, Cyril, Kochbati, Eloïse, Orlanducci, Florence, Charbonnier, Aude, D’Incan, Evelyne, Andre, Pascale, Romagne, François, Barbarat, Bernadette, Vey, Norbert, Olive, Daniel
Publicado en Front Immunol (2017)

Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase

por Brecqueville, Mandy, Rey, Jérôme, Devillier, Raynier, Guille, Arnaud, Gillet, Rémi, Adélaide, José, Gelsi-Boyer, Véronique, Arnoulet, Christine, Chaffanet, Max, Mozziconacci, Marie-Joelle, Vey, Norbert, Birnbaum, Daniel, Murati, Anne
Publicado 2014

Genomic analysis of myeloproliferative neoplasms in chronic and acute phases

por Courtier, Frédéric, Carbuccia, Nadine, Garnier, Séverine, Guille, Arnaud, Adélaïde, José, Cervera, Nathalie, Gelsi-Boyer, Véronique, Mozziconacci, Marie-Joelle, Rey, Jérôme, Vey, Norbert, Chaffanet, Max, Birnbaum, Daniel, Murati, Anne
Publicado en Haematologica (2017)

A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies

por Vey, Norbert, Karlin, Lionel, Sadot-Lebouvier, Sophie, Broussais, Florence, Berton-Rigaud, Dominique, Rey, Jérôme, Charbonnier, Aude, Marie, Delphine, André, Pascale, Paturel, Carine, Zerbib, Robert, Bennouna, Jaafar, Salles, Gilles, Gonçalves, Anthony
Publicado en Oncotarget (2018)

Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo

por Verger, Emmanuelle, Soret-Dulphy, Juliette, Maslah, Nabih, Roy, Lydia, Rey, Jerome, Ghrieb, Zineb, Kralovics, Robert, Gisslinger, Heinz, Grohmann-Izay, Barbara, Klade, Christoph, Chomienne, Christine, Giraudier, Stéphane, Cassinat, Bruno, Kiladjian, Jean-Jacques
Publicado en Blood Cancer J (2018)

NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML

por Chretien, Anne-Sophie, Devillier, Raynier, Fauriat, Cyril, Orlanducci, Florence, Harbi, Samia, Le Roy, Aude, Rey, Jérôme, Bouvier Borg, Gaelle, Gautherot, Emmanuel, Hamel, Jean-François, Ifrah, Norbert, Lacombe, Catherine, Cornillet-Lefebvre, Pascale, Delaunay, Jacques, Toubert, Antoine, Arnoulet, Christine, Vey, Norbert, Blaise, Didier, Olive, Daniel
Publicado en Oncoimmunology (2017)

NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia

por Chretien, Anne-Sophie, Fauriat, Cyril, Orlanducci, Florence, Rey, Jerome, Borg, Gaelle Bouvier, Gautherot, Emmanuel, Granjeaud, Samuel, Demerle, Clemence, Hamel, Jean-François, Cerwenka, Adelheid, von Strandmann, Elke Pogge, Ifrah, Norbert, Lacombe, Catherine, Cornillet-Lefebvre, Pascale, Delaunay, Jacques, Toubert, Antoine, Arnoulet, Christine, Vey, Norbert, Olive, Daniel
Publicado en Oncotarget (2017)

Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia

por Chretien, Anne-Sophie, Fauriat, Cyril, Orlanducci, Florence, Rey, Jerome, Borg, Gaelle Bouvier, Gautherot, Emmanuel, Granjeaud, Samuel, Demerle, Clemence, Hamel, Jean-François, Cerwenka, Adelheid, von Strandmann, Elke Pogge, Ifrah, Norbert, Lacombe, Catherine, Cornillet-Lefebvre, Pascale, Delaunay, Jacques, Toubert, Antoine, Arnoulet, Christine, Vey, Norbert, Olive, Daniel
Publicado en Oncotarget (2019)

Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms...

por Ianotto, Jean-Christophe, Chauveau, Aurélie, Boyer-Perrard, Françoise, Gyan, Emmanuel, Laribi, Kamel, Cony-Makhoul, Pascale, Demory, Jean-Loup, de Renzis, Benoit, Dosquet, Christine, Rey, Jerome, Roy, Lydia, Dupriez, Brigitte, Knoops, Laurent, Legros, Laurence, Malou, Mohamed, Hutin, Pascal, Ranta, Dana, Benbrahim, Omar, Ugo, Valérie, Lippert, Eric, Kiladjian, Jean-Jacques
Publicado en Haematologica (2018)

Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia

por Chretien, Anne-Sophie, Fauriat, Cyril, Orlanducci, Florence, Galseran, Claire, Rey, Jerome, Bouvier Borg, Gaelle, Gautherot, Emmanuel, Granjeaud, Samuel, Hamel-Broza, Jean-François, Demerle, Clemence, Ifrah, Norbert, Lacombe, Catherine, Cornillet-Lefebvre, Pascale, Delaunay, Jacques, Toubert, Antoine, Gregori, Emilie, Luche, Herve, Malissen, Marie, Arnoulet, Christine, Nunes, Jacques A., Vey, Norbert, Olive, Daniel
Publicado en Front Immunol (2017)

Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients

por Malard, Florent, Vekhoff, Anne, Lapusan, Simona, Isnard, Francoise, D’incan-Corda, Evelyne, Rey, Jérôme, Saillard, Colombe, Thomas, Xavier, Ducastelle-Lepretre, Sophie, Paubelle, Etienne, Larcher, Marie-Virginie, Rocher, Clément, Recher, Christian, Tavitian, Suzanne, Bertoli, Sarah, Michallet, Anne-Sophie, Gilis, Lila, Peterlin, Pierre, Chevallier, Patrice, Nguyen, Stéphanie, Plantamura, Emilie, Boucinha, Lilia, Gasc, Cyrielle, Michallet, Mauricette, Dore, Joel, Legrand, Ollivier, Mohty, Mohamad
Publicado en Nat Commun (2021)

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study

por Luque Paz, Damien, Riou, Jérémie, Verger, Emmanuelle, Cassinat, Bruno, Chauveau, Aurélie, Ianotto, Jean-Christophe, Dupriez, Brigitte, Boyer, Françoise, Renard, Maxime, Mansier, Olivier, Murati, Anne, Rey, Jérôme, Etienne, Gabriel, Mansat-De Mas, Véronique, Tavitian, Suzanne, Nibourel, Olivier, Girault, Stéphane, Le Bris, Yannick, Girodon, François, Ranta, Dana, Chomel, Jean-Claude, Cony-Makhoul, Pascale, Sujobert, Pierre, Robles, Margot, Ben Abdelali, Raouf, Kosmider, Olivier, Cottin, Laurane, Roy, Lydia, Sloma, Ivan, Vacheret, Fabienne, Wemeau, Mathieu, Mossuz, Pascal, Slama, Borhane, Cussac, Vincent, Denis, Guillaume, Walter-Petrich, Anouk, Burroni, Barbara, Jézéquel, Nathalie, Giraudier, Stéphane, Lippert, Eric, Socié, Gérard, Kiladjian, Jean-Jacques, Ugo, Valérie
Publicado en Blood Adv (2021)